Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0PJ7M
|
|||
| Drug Name |
1,2-dihydroindazolo[4,3-bc][1,5]benzoxazepine derivative 1
|
|||
| Synonyms |
PMID25684022-Compound-WO2010120854
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Metastatic cancer [ICD-11: 2D50-2E2Z] | Patented | [1] | |
| Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Patented | [1] | ||
| Company |
GLAXOSMITHKLINE LLC AXTEN, Jeffrey, Michael BRADY, Gerald, Patrick, Jr. GALLAGHER, Timothy, Francis HEERDING, Dirk, A. MEDINA, Jesus, Raul ROMERIL, Stuart, Paul
|
|||
| Structure |
 |
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Pyruvate dehydrogenase kinase 1 (PDHK1) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Pyruvate dehydrogenase kinase 1 (PDHK1) | Target's Patent Info | [1] | |
| KEGG Pathway | HIF-1 signaling pathway | |||
| Axon guidance | ||||
| Central carbon metabolism in cancer | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | PDK1 disruptors and modulators: a patent review.Expert Opin Ther Pat. 2015 May;25(5):513-37. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.